These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 6224993)

  • 1. Reactions in leprosy.
    Bjune G
    Lepr Rev; 1983 Jun; Spec No():61-7. PubMed ID: 6224993
    [No Abstract]   [Full Text] [Related]  

  • 2. Presence of soluble, Mycobacterium leprae-derived antigen in the inflammatory exudate of reactional lepromatous leprosy.
    Rojas-Espinosa O; González-Mendoza A; Estrada-Parra S; Ortíz Y; González-Cruz O; Cornejo AL; Pérez-Suarez G
    Lepr Rev; 1985 Sep; 56(3):229-38. PubMed ID: 3903409
    [No Abstract]   [Full Text] [Related]  

  • 3. Type 1 reactions in leprosy--heterogeneity in T-cell functions related to the background leprosy type.
    Laal S; Mishra RS; Nath I
    Int J Lepr Other Mycobact Dis; 1987 Sep; 55(3):481-93. PubMed ID: 2958570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological aspects of leprosy: ten years' activity at the Armauer Hansen Research Institute and Prospects for further work.
    Harboe M
    Int J Lepr Other Mycobact Dis; 1980 Jun; 48(2):193-205. PubMed ID: 6156919
    [No Abstract]   [Full Text] [Related]  

  • 5. The immunopathology of erythema nodosum leprosum: the role of extravascular complexes.
    Ridley MJ; Ridley DS
    Lepr Rev; 1983 Jun; 54(2):95-107. PubMed ID: 6350778
    [No Abstract]   [Full Text] [Related]  

  • 6. Importance of immune reactions in leprosy.
    Harboe M
    Ethiop Med J; 1976 Oct; 14(4):205-12. PubMed ID: 799966
    [No Abstract]   [Full Text] [Related]  

  • 7. Monoclonal antibodies against Mycobacterium leprae and their applications in leprosy research.
    Sengupta U; Sinha S
    Indian J Lepr; 1984; 56(4):727-41. PubMed ID: 6398337
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacologically-active mediators of hypersensitivity reactions in the blood of lepromatous patients with erythema nodosum leprosum.
    Saha K; Lahiri SC
    Lepr Rev; 1981 Dec; 52(4):315-20. PubMed ID: 7031390
    [No Abstract]   [Full Text] [Related]  

  • 9. Natural emergence of antigen-reactive T cells in lepromatous leprosy patients during erythema nodosum leprosum.
    Laal S; Bhutani LK; Nath I
    Infect Immun; 1985 Dec; 50(3):887-92. PubMed ID: 2933339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In situ identification of activated Ta1+ T lymphocytes in human leprosy skin lesions.
    Shen JY; Hofman FM; Gunter JR; Modlin RL; Rea TH
    Int J Lepr Other Mycobact Dis; 1987 Sep; 55(3):494-8. PubMed ID: 2443587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of immunosuppression and immunodeficiency on infections with leprosy and tuberculosis.
    Strickland NH
    Int J Lepr Other Mycobact Dis; 1985 Mar; 53(1):86-100. PubMed ID: 2987376
    [No Abstract]   [Full Text] [Related]  

  • 12. Early events in the host-parasite relationship and immune response in clinical leprosy: its possible importance for leprosy control.
    Bjune G; Closs O; Barnetson RS
    Clin Exp Immunol; 1983 Nov; 54(2):289-97. PubMed ID: 6228348
    [No Abstract]   [Full Text] [Related]  

  • 13. Changes in circulating antibody levels to the major phenolic glycolipid during erythema nodosum leprosum in leprosy patients.
    Andreoli A; Brett SJ; Draper P; Payne SN; Rook GA
    Int J Lepr Other Mycobact Dis; 1985 Jun; 53(2):211-7. PubMed ID: 3894538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Etiological factors in delayed-type hypersensitivity reactions in leprosy.
    Klenerman P
    Int J Lepr Other Mycobact Dis; 1987 Dec; 55(4):702-12. PubMed ID: 3123582
    [No Abstract]   [Full Text] [Related]  

  • 15. The immunopharmacology of antileprosy agents.
    Anderson R
    Lepr Rev; 1983 Jun; 54(2):139-44. PubMed ID: 6350776
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy of a cell-mediated reaction to the purified protein derivative of tuberculin in the disposal of Mycobacterium leprae from human skin.
    Kaplan G; Sheftel G; Job CK; Mathur NK; Nath I; Cohn ZA
    Proc Natl Acad Sci U S A; 1988 Jul; 85(14):5210-4. PubMed ID: 2969108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The detection of Mycobacterium leprae protein and carbohydrate antigens in skin and nerve from leprosy patients with type 1 (reversal) reactions.
    Lockwood DN; Colston MJ; Khanolkar-Young SR
    Am J Trop Med Hyg; 2002 Apr; 66(4):409-15. PubMed ID: 12164297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA class II restricted helper and suppressor clones reactive with Mycobacterium leprae.
    de Vries RR; Ottenhoff TH; Li SG; Young RA
    Lepr Rev; 1986 Dec; 57 Suppl 2():113-21. PubMed ID: 2952853
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunohistological studies of skin biopsies from patients with lepromatous leprosy.
    Mshana RN; Humber DP; Belehu A; Harboe M
    J Clin Immunol; 1983 Jan; 3(1):22-9. PubMed ID: 6338025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunology of human leprosy--current status.
    Nath I
    Lepr Rev; 1983 Jun; Spec No():31-45. PubMed ID: 6224992
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.